It’s never too early in the research and development (R&D) process to identify and ...
For more than 25 years, the 340B Drug Pricing Program1 has helped safety-net facilities ...
In the dramatically changing pharma industry, one key trend that overlays providers of care, ...
Priced at a staggering $2.125 million per patient, Zolgensma is now the world’s most ...
With the Bipartisan Budget Act of 2018 (BBA), Congress made changes to the Medicare ...